Longitudinal serum S100β and brain aging in the Lothian Birth Cohort 1936
暂无分享,去创建一个
Benjamin S. Aribisala | Stuart J. Ritchie | I. Deary | M. Bastin | J. Starr | J. Wardlaw | M. V. Valdés Hernández | S. Muñoz Maniega | S. Harris | S. Cox | M. Allerhand | D. Dickie | Z. Morris | S. Ritchie | D. Anblagan | R. Sherwood | N. Abbott | D. A. Dickie | S. Harris
[1] R. Anderson,et al. High Serum S100B Levels for Trauma Patients without Head Injuries , 2001, Neurosurgery.
[2] C. Beaulieu,et al. The basis of anisotropic water diffusion in the nervous system – a technical review , 2002, NMR in biomedicine.
[3] J. Wardlaw,et al. Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study , 2017, Alzheimer's & Dementia.
[4] J. van os,et al. Serum S100B: A proxy marker for grey and white matter status in the absence and presence of (increased risk of) psychotic disorder? , 2017, PloS one.
[5] Karen J. Ferguson,et al. Enlarged Perivascular Spaces on MRI Are a Feature of Cerebral Small Vessel Disease , 2010, Stroke.
[6] K. Tziridis,et al. S100B in serum and saliva: a valid invasive or non-invasive biomarker in obstructive sleep apnea? , 2016, European review for medical and pharmacological sciences.
[7] Peng Yuan,et al. Regional brain shrinkage over two years: Individual differences and effects of pro-inflammatory genetic polymorphisms , 2014, NeuroImage.
[8] L. Wilkins. What are White Matter Hyperintensities Made of? , 2016, Journal of the American Heart Association.
[9] Thomas R. Knösche,et al. White matter integrity, fiber count, and other fallacies: The do's and don'ts of diffusion MRI , 2013, NeuroImage.
[10] Paul M. Thompson,et al. Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk , 2018, NeuroImage.
[11] P. Hofman,et al. Blood–brain barrier leakage is more widespread in patients with cerebral small vessel disease , 2017, Neurology.
[12] E. Thompson,et al. Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern , 2003, Brain Research Bulletin.
[13] F. Michetti,et al. Pediatric concentrations of S100B protein in blood: age- and sex-related changes. , 2003, Clinical chemistry.
[14] B. Romner,et al. Biochemical serum markers of traumatic brain injury. , 2002, The Journal of trauma.
[15] B. Romner,et al. Age- and Sex-Related Changes of S-100 Protein Concentrations in Cerebrospinal Fluid and Serum in Patients with No Previous History of Neurological Disorder , 1997 .
[16] H. Sauer,et al. Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia , 2016, Front. Cell. Neurosci..
[17] R. Donato,et al. Functions of S100 proteins. , 2012, Current molecular medicine.
[18] M. Schroeter,et al. Glial pathology is modified by age in mood disorders--a systematic meta-analysis of serum S100B in vivo studies. , 2011, Journal of affective disorders.
[19] R. Harpio,et al. S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma. , 2004, Clinical biochemistry.
[20] Joanna M. Wardlaw,et al. Vascular risk factors and progression of white matter hyperintensities in the Lothian Birth Cohort 1936 , 2016, Neurobiology of Aging.
[21] M. Wiesmann,et al. Plasma S-100b protein concentration in healthy adults is age- and sex-independent. , 1998, Clinical Chemistry.
[22] Emma J. Telford,et al. A latent measure explains substantial variance in white matter microstructure across the newborn human brain , 2017, Brain Structure and Function.
[23] Yves Rosseel,et al. lavaan: An R Package for Structural Equation Modeling , 2012 .
[24] G. Borm,et al. Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid. , 1992, Clinical chemistry.
[25] Joanna M Wardlaw,et al. What are White Matter Hyperintensities Made of? , 2015, Journal of the American Heart Association.
[26] I. Deary,et al. Brain Aging, Cognition in Youth and Old Age and Vascular Disease in the Lothian Birth Cohort 1936: Rationale, Design and Methodology of the Imaging Protocol* , 2011, International journal of stroke : official journal of the International Stroke Society.
[27] P. Schoenknecht,et al. First evidence for glial pathology in late life minor depression: S100B is increased in males with minor depression , 2015, Front. Cell. Neurosci..
[28] Alan C. Evans,et al. A voxel-based morphometric study to determine individual differences in gray matter density associated with age and cognitive change over time. , 2004, Cerebral cortex.
[29] P. Visscher,et al. The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond , 2007, BMC geriatrics.
[30] Enrico Pellegrini,et al. Application of the Ordered Logit Model to Optimising Frangi Filter Parameters for Segmentation of Perivascular Spaces , 2016, MIUA.
[31] F. Paul,et al. Perivascular spaces--MRI marker of inflammatory activity in the brain? , 2008, Brain : a journal of neurology.
[32] R. Schmidhammer,et al. Circulating S100B is increased after bilateral femur fracture without brain injury in the rat. , 2003, British journal of anaesthesia.
[33] R. Donato,et al. Intracellular and extracellular roles of S100 proteins , 2003, Microscopy research and technique.
[34] Ian J Deary,et al. Cohort profile: the Lothian Birth Cohorts of 1921 and 1936. , 2012, International journal of epidemiology.
[35] Joanna M. Wardlaw,et al. Quantifying the effects of normal ageing on white matter structure using unsupervised tract shape modelling , 2010, NeuroImage.
[36] Jacob Cohen,et al. A power primer. , 1992, Psychological bulletin.
[37] A. Fabio,et al. S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. , 2013, Journal of neurotrauma.
[38] R. Sherwood,et al. Serum S100β protein as a marker of disease activity in patients with malignant melanoma , 2001 .
[39] Amos Storkey,et al. TractoR: Magnetic Resonance Imaging and Tractography with R , 2011 .
[40] T. Beems,et al. GFAP and S100B are biomarkers of traumatic brain injury , 2010, Neurology.
[41] J Perl,et al. Serum S-100β as a possible marker of blood–brain barrier disruption , 2002, Brain Research.
[42] J. Wardlaw,et al. Cerebral Perivascular Spaces Visible on Magnetic Resonance Imaging: Development of a Qualitative Rating Scale and its Observer Reliability , 2015, Cerebrovascular Diseases.
[43] Susana Muñoz Maniega,et al. Coupled Changes in Brain White Matter Microstructure and Fluid Intelligence in Later Life , 2015, The Journal of Neuroscience.
[44] Joanna M. Wardlaw,et al. A General Factor of Brain White Matter Integrity Predicts Information Processing Speed in Healthy Older People , 2010, The Journal of Neuroscience.
[45] Karen J. Ferguson,et al. New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images , 2010, European Radiology.
[46] Mark E Bastin,et al. Ageing and brain white matter structure in 3,513 UK Biobank participants , 2016, Nature Communications.
[47] Hammad Naveed,et al. The effect of systemic inflammation on human brain barrier function , 2017, Brain, Behavior, and Immunity.
[48] A. Villringer,et al. Validating Serum S100B and Neuron-Specific Enolase as Biomarkers for the Human Brain – A Combined Serum, Gene Expression and MRI Study , 2012, PloS one.
[49] M. Wiesmann,et al. Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. , 1999, Clinical chemistry.
[50] E. Peskind,et al. Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease , 2001, Neurochemistry International.
[51] C. Sudlow,et al. Enlarged perivascular spaces and cerebral small vessel disease , 2013, International journal of stroke : official journal of the International Stroke Society.
[52] J. Mcardle. Latent variable modeling of differences and changes with longitudinal data. , 2009, Annual review of psychology.
[53] Jason K. W. Lee,et al. S100B as a Marker for Brain Damage and Blood–Brain Barrier Disruption Following Exercise , 2014, Sports Medicine.
[54] M. Buchfelder,et al. The Passage of S100B from Brain to Blood Is Not Specifically Related to the Blood-Brain Barrier Integrity , 2010, Cardiovascular psychiatry and neurology.
[55] E. Thelin,et al. A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury , 2016, Acta Neurochirurgica.
[56] P. Abreu-González,et al. Summer/winter changes in serum S100B protein concentration as a source of research variance. , 2013, Journal of psychiatric research.
[57] J. Wang,et al. Study on adhesion, proliferation and differentiation of osteoblasts promoted by new absorbable bioactive glass injection in vitro. , 2016, European review for medical and pharmacological sciences.
[58] Benjamin S Aribisala,et al. Circulating Inflammatory Markers Are Associated With Magnetic Resonance Imaging-Visible Perivascular Spaces But Not Directly With White Matter Hyperintensities , 2014, Stroke.
[59] D. Souza,et al. Serum levels of S100B and NSE proteins in Alzheimer's disease patients , 2010, Journal of Neuroinflammation.
[60] Flávio Kapczinski,et al. The serum S100B concentration is age dependent. , 2002, Clinical chemistry.
[61] Cathie Sudlow,et al. Lacunar stroke is associated with diffuse blood–brain barrier dysfunction , 2009, Annals of neurology.
[62] Nancy L. Pedersen,et al. Biological Age Predictors , 2017, EBioMedicine.
[63] Taku Komura,et al. Medical Image Understanding and Analysis (MIUA 2017) , 2017 .
[64] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[65] L. Dosemeci,et al. Comparison of serum and cerebrospinal fluid protein S-100b levels after severe head injury and their prognostic importance. , 2004, The Journal of trauma.
[66] J. Schafer,et al. Missing data: our view of the state of the art. , 2002, Psychological methods.
[67] S. Mocellin,et al. The prognostic value of serum S100B in patients with cutaneous melanoma: A meta‐analysis , 2008, International journal of cancer.
[68] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[69] V. Arolt,et al. S100B in brain damage and neurodegeneration , 2003, Microscopy research and technique.